Brace Pharma logo

Brace Pharma

North America, Maryland, United States, Rockville

Description

Brace Pharma is a Maryland- based investment company specialized in investments in clinical-stage projects.

Investor Profile

Brace Pharma has made 20 investments, with 0 in the past 12 months and 10% as lead.

Stage Focus

  • Series B (40%)
  • Series C (30%)
  • Series D (10%)
  • Private Equity (10%)
  • Series A (10%)

Country Focus

  • United States (70%)
  • United Kingdom (25%)
  • Canada (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Genetics
  • Life Science
  • Biopharma
  • Developer Platform
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Brace Pharma frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 4
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
Sectoral Asset Management
North America, Quebec, Canada, Montréal
Co-Investments: 5
CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 4
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 4
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 5

Which angels does Brace Pharma often collaborate with?

RS
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Brace Pharma?

Antiva Biosciences

Del Mar, California, United States

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

BiotechnologyHealth CareMedical
Series DNov 2, 2021
Amount Raised: $31,000,000
Turnstone Biologics

La Jolla, California, United States

Turnstone Biologics is a privately-held clinical stage biotech company.

BiotechnologyInnovation ManagementTherapeutics
Series DJul 14, 2021
Amount Raised: $79,999,979
Pipeline Therapeutics

San Diego, California, United States

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CFeb 11, 2021
Amount Raised: $80,000,000
ReViral

Stevenage, Herefordshire, United Kingdom

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

BiotechnologyHealth CareMedicalTherapeutics
Series CAug 25, 2020
Amount Raised: $44,000,000
F2G

Manchester, Manchester, United Kingdom

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Private EquityAug 12, 2020
Amount Raised: $60,800,000
HotSpot Therapeutics

Boston, Massachusetts, United States

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series BMay 21, 2020
Amount Raised: $65,000,000
Pipeline Therapeutics

San Diego, California, United States

Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series BDec 18, 2019
Amount Raised: $32,000,000
Avidity Biosciences

San Diego, California, United States

Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.

BiotechnologyHealth CareLife SciencePharmaceuticalTherapeutics
Series CNov 13, 2019
Amount Raised: $100,000,000
ReViral

Stevenage, Herefordshire, United Kingdom

ReViral is a biotechnology company that develops and offers antiviral therapies for patients.

BiotechnologyHealth CareMedicalTherapeutics
Series BAug 1, 2018
Amount Raised: $55,000,000
Antiva Biosciences

Del Mar, California, United States

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

BiotechnologyHealth CareMedical
Series CJul 10, 2018
Amount Raised: $15,000,000